Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development

od Gibbs, John P., Menon, Rajeev, Kasichayanula, Sreeneeranj
Wydane w Clin Pharmacol Ther (2017)

Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer

od Zhang, Yilong, Kuchimanchi, Mita, Zhu, Min, Doshi, Sameer, Hoang, Tien, Kasichayanula, Sreeneeranj
Wydane w Br J Clin Pharmacol (2016)

Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor

od Kasichayanula, Sreeneeranj, Grover, Anita, Emery, Maurice G., Gibbs, Megan A., Somaratne, Ransi, Wasserman, Scott M., Gibbs, John P.
Wydane w Clin Pharmacokinet (2018)

Simultaneous oral therapeutic and intravenous (14)C‐microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin

od Boulton, David W., Kasichayanula, Sreeneeranj, Keung, Chi Fung (Anther), Arnold, Mark E., Christopher, Lisa J., Xu, Xiaohui (Sophia), LaCreta, Frank
Wydane 2013

The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus

od Kasichayanula, Sreeneeranj, Liu, Xiaoni, Pe Benito, Melanie, Yao, Ming, Pfister, Marc, LaCreta, Frank P, Humphreys, William Griffith, Boulton, David W
Wydane 2013

Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects

od Kasichayanula, Sreeneeranj, Boulton, David W, Luo, Wen-Lin, Rodrigues, A David, Yang, Zheng, Goodenough, Angela, Lee, Michelle, Jemal, Mohammed, LaCreta, Frank
Wydane w Br J Clin Pharmacol (2014)

Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety

od Lee, Edward, Gibbs, John P., Emery, Maurice G., Block, Geoffrey, Wasserman, Scott M., Hamilton, Lisa, Kasichayanula, Sreeneeranj, Hanafin, Patrick, Somaratne, Ransi, Egbuna, Ogo
Wydane w Clin Pharmacol Drug Dev (2019)

Crowdsourced Asparagus Urinary Odor Population Kinetics

od Ramamoorthy, Anuradha, Sadler, Brian M., van Hasselt, J.G. Coen, Elassaiss‐Schaap, Jeroen, Kasichayanula, Sreeneeranj, Edwards, Alena Y., van der Graaf, Piet H., Zhang, Lei, Wagner, John A.
Wydane w CPT Pharmacometrics Syst Pharmacol (2017)

Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes

od DeFronzo, Ralph A., Hompesch, Marcus, Kasichayanula, Sreeneeranj, Liu, Xiaoni, Hong, Ying, Pfister, Marc, Morrow, Linda A., Leslie, Bruce R., Boulton, David W., Ching, Agatha, LaCreta, Frank P., Griffen, Steven C.
Wydane 2013

Model Informed Dosing Regimen and Phase I Results of the Anti‐PD‐1 Antibody Budigalimab (ABBV‐181)

od Powderly, John, Spira, Alexander, Kondo, Shunsuke, Doi, Toshihiko, Luke, Jason J., Rasco, Drew, Gao, Bo, Tanner, Minna, Cassier, Philippe A., Gazzah, Anas, Italiano, Antoine, Tosi, Diego, Afar, Daniel E., Parikh, Apurvasena, Engelhardt, Benjamin, Englert, Stefan, Lambert, Stacie L., Kasichayanula, Sreeneeranj, Mensing, Sven, Menon, Rajeev, Vosganian, Gregory, Tolcher, Anthony
Wydane w Clin Transl Sci (2020)